JPWO2023120561A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023120561A5 JPWO2023120561A5 JP2023501876A JP2023501876A JPWO2023120561A5 JP WO2023120561 A5 JPWO2023120561 A5 JP WO2023120561A5 JP 2023501876 A JP2023501876 A JP 2023501876A JP 2023501876 A JP2023501876 A JP 2023501876A JP WO2023120561 A5 JPWO2023120561 A5 JP WO2023120561A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibody variant
- nemolizumab
- pharmaceutical composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023134673A JP7812826B2 (ja) | 2021-12-22 | 2023-08-22 | 生物活性が低下した抗体バリアント |
| JP2026012833A JP2026063423A (ja) | 2021-12-22 | 2026-01-29 | 生物活性が低下した抗体バリアント |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021207714 | 2021-12-22 | ||
| JP2021207714 | 2021-12-22 | ||
| PCT/JP2022/047035 WO2023120561A1 (ja) | 2021-12-22 | 2022-12-21 | 生物活性が低下した抗体バリアント |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023134673A Division JP7812826B2 (ja) | 2021-12-22 | 2023-08-22 | 生物活性が低下した抗体バリアント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023120561A1 JPWO2023120561A1 (https=) | 2023-06-29 |
| JPWO2023120561A5 true JPWO2023120561A5 (https=) | 2023-11-22 |
| JP7721630B2 JP7721630B2 (ja) | 2025-08-12 |
Family
ID=86902603
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501876A Active JP7721630B2 (ja) | 2021-12-22 | 2022-12-21 | 生物活性が低下した抗体バリアント |
| JP2023134673A Active JP7812826B2 (ja) | 2021-12-22 | 2023-08-22 | 生物活性が低下した抗体バリアント |
| JP2026012833A Pending JP2026063423A (ja) | 2021-12-22 | 2026-01-29 | 生物活性が低下した抗体バリアント |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023134673A Active JP7812826B2 (ja) | 2021-12-22 | 2023-08-22 | 生物活性が低下した抗体バリアント |
| JP2026012833A Pending JP2026063423A (ja) | 2021-12-22 | 2026-01-29 | 生物活性が低下した抗体バリアント |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250163163A1 (https=) |
| EP (1) | EP4455163A4 (https=) |
| JP (3) | JP7721630B2 (https=) |
| KR (2) | KR102902883B1 (https=) |
| CN (1) | CN118613503A (https=) |
| TW (1) | TW202340249A (https=) |
| WO (1) | WO2023120561A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5954916B1 (ja) | 2015-04-14 | 2016-07-20 | 中外製薬株式会社 | Ｉｌ−３１アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び／又は治療用医薬組成物 |
| MX2022005654A (es) | 2019-11-20 | 2022-06-22 | Chugai Pharmaceutical Co Ltd | Preparacion que contiene anticuerpo. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101225299B1 (ko) * | 2003-12-10 | 2013-01-24 | 메다렉스, 인코포레이티드 | 인터페론 알파 항체 및 그의 용도 |
| ES2429407T3 (es) | 2006-06-08 | 2013-11-14 | Chugai Seiyaku Kabushiki Kaisha | Agente preventivo o remedio para enfermedades inflamatorias |
| TW201634479A (zh) | 2007-12-05 | 2016-10-01 | 中外製藥股份有限公司 | 抗ｎｒ１０抗體及其應用 |
| JP2010210772A (ja) | 2009-03-13 | 2010-09-24 | Dainippon Screen Mfg Co Ltd | 液晶表示装置の製造方法 |
| CN119161488A (zh) * | 2017-11-01 | 2024-12-20 | 中外制药株式会社 | 具有降低的生物活性的抗体变体和同种型 |
| JP7840636B2 (ja) * | 2018-04-02 | 2026-04-06 | アムジェン インコーポレイテッド | エレヌマブ組成物及びその使用 |
| MX2022005654A (es) | 2019-11-20 | 2022-06-22 | Chugai Pharmaceutical Co Ltd | Preparacion que contiene anticuerpo. |
-
2022
- 2022-12-21 WO PCT/JP2022/047035 patent/WO2023120561A1/ja not_active Ceased
- 2022-12-21 KR KR1020237004346A patent/KR102902883B1/ko active Active
- 2022-12-21 KR KR1020257042067A patent/KR20260007630A/ko active Pending
- 2022-12-21 CN CN202280089597.4A patent/CN118613503A/zh active Pending
- 2022-12-21 TW TW111149176A patent/TW202340249A/zh unknown
- 2022-12-21 US US18/721,311 patent/US20250163163A1/en active Pending
- 2022-12-21 JP JP2023501876A patent/JP7721630B2/ja active Active
- 2022-12-21 EP EP22911263.6A patent/EP4455163A4/en active Pending
-
2023
- 2023-08-22 JP JP2023134673A patent/JP7812826B2/ja active Active
-
2026
- 2026-01-29 JP JP2026012833A patent/JP2026063423A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023120561A5 (https=) | ||
| RU2015141428A (ru) | Антитела, связывающие il-4 и/или il-13, и их применение | |
| JP7189211B2 (ja) | 血清中のタンパク質の半減期を増加させるための組成物及び方法 | |
| JP2020518248A5 (https=) | ||
| JP2021530244A5 (https=) | ||
| JP2016531546A5 (https=) | ||
| US11180536B2 (en) | Antibodies to royalactin and uses thereof | |
| CN117720650B (zh) | 抗人呼吸道合胞病毒抗体及其应用 | |
| JP2015514068A5 (https=) | ||
| JP2021529749A (ja) | 混合物からポリペプチドを調製するための複数の疎水性相互作用クロマトグラフィーの使用 | |
| WO2020072996A1 (en) | Newborn screening for primary immunodeficiencies, cystinosis, and wilson disease | |
| US10233256B2 (en) | Antibodies directed to ricin toxin | |
| CN116640220A (zh) | 一种结合幽门螺旋杆菌抗原蛋白尿素酶的抗体及其应用 | |
| US10208108B2 (en) | Antibodies directed to ricin toxin | |
| JP2024023268A5 (https=) | ||
| KR102421918B1 (ko) | 호산구 유래 신경독과 특이적으로 결합하는 단일클론항체 및 이의 용도 | |
| WO2021065846A1 (ja) | 抗ＨＩＶ－１ Ｖ３抗体１Ｃ１０（０．５γ）に結合する抗体及びその抗原結合断片並びにその応用 | |
| EP3102637B1 (en) | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | |
| CN110724671A (zh) | 杂交瘤细胞株1g8、抗体及其应用 | |
| JP5448424B2 (ja) | ヒトＩｇＧのＦｃを含有するタンパク質の測定試薬 | |
| CN116410325A (zh) | 一种新型抗独特型抗体的纯化制备方法 | |
| US20220242939A1 (en) | Antibody directed against the apoe amino-terminal fragment of 12kda | |
| RU2024102685A (ru) | Варианты и изоформы антител с пониженной биологической активностью | |
| RU2025110616A (ru) | CD163 Связывающий белок | |
| CN117487021A (zh) | 一种抗人IgG蛋白的抗体及其应用 |